Point72 Hong Kong’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,800
Closed -$586K 827
2022
Q3
$586K Buy
1,800
+400
+29% +$147K 0.02% 695
2022
Q2
$491K Sell
1,400
-500
-26% -$204K 0.02% 714
2022
Q1
$1.04M Sell
1,900
-1,400
-42% -$736K 0.04% 498
2021
Q4
$2.17M Sell
3,300
-400
-11% -$251K 0.08% 312
2021
Q3
$2.3M Sell
3,700
-2,900
-44% -$1.95M 0.07% 396
2021
Q2
$4.17M Buy
6,600
+2,800
+74% +$1.55M 0.14% 165
2021
Q1
$1.86M Buy
3,800
+1,900
+100% +$952K 0.06% 421
2020
Q4
$950K Buy
+1,900
New +$850K 0.04% 495

Other funds holding IDXX

Point72 Hong Kong's IDXX Position: Q2 2024 in Review

Point72 Hong Kong sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 18,007 shares — an estimated $9.72M sold.

Point72 Hong Kong first reported a position in IDXX in Q3 2014 and held it in 18 quarters. The position peaked at $11.3M in Q4 2023. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • Point72 Hong Kong reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 18,007 Idexx Laboratories shares in Q2 2024, an estimated $9.72M.
  • Point72 Hong Kong first reported a position in Idexx Laboratories in Q3 2014 and held it in 18 quarters.
  • Point72 Hong Kong's Idexx Laboratories position peaked at $11.3M in Q4 2023.
  • 1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Point72 Hong Kong's 13F filing for Q2 2024, filed 14 Aug 2024.